RT Journal Article
SR Electronic
T1 Assessing liver fibrosis without biopsy in patients with HCV or NAFLD
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 179
OP 186
DO 10.3949/ccjm.86a.17118
VO 86
IS 3
A1 Tavankit Singh
A1 Daniela S. Allende
A1 Arthur J. McCullough
YR 2019
UL http://www.ccjm.org/content/86/3/179.abstract
AB Staging of liver fibrosis is increasingly done using noninvasive methods, in some cases obviating the need for liver biopsy. Scores based on laboratory values and demographic variables have been developed and validated for assessing fibrosis in patients with hepatitis C virus (HCV) infection and nonalcoholic fatty liver disease (NAFLD), as have several imaging methods that measure shear-wave velocity, a reflection of fibrosis severity.